BioRestorative Therapies Announces Clinical Site Initiation for the Company's Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD) Seite 1
13.06.2022 - - First Site Will Enroll First Patient in the Clinical Study- MELVILLE, NY., June 13, 2022 (GLOBE NEWSWIRE) - BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ: BRTX), a clinical stage company focused on stem ... Seite 1